R
Richard L. Davis
Researcher at Stanford University
Publications - 181
Citations - 14884
Richard L. Davis is an academic researcher from Stanford University. The author has contributed to research in topics: Anaplastic astrocytoma & Radiation therapy. The author has an hindex of 60, co-authored 177 publications receiving 14446 citations. Previous affiliations of Richard L. Davis include University of California, Los Angeles & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.
Joshua B. Bederson,Lawrence H. Pitts,Miles Tsuji,Merry C. Nishimura,Richard L. Davis,Henry M. Bartkowski +5 more
TL;DR: In this article, the authors examined the incidence and size of infarction after occlusion of different portions of the rat middle cerebral artery (MCA) in order to define the reliability and predictability of this model of brain ischemia.
Journal ArticleDOI
Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.
Joshua B. Bederson,Lawrence H. Pitts,Sabelle M. Germano,Merry C. Nishimura,Richard L. Davis,Henry M. Bartkowski +5 more
TL;DR: Staining with TTC is a rapid, convenient, inexpensive, and reliable method for the detection and quantification of cerebral infarction in rats 24 hr after the onset of ischemia.
Journal ArticleDOI
Primary malignant lymphomas of the central nervous system
TL;DR: The authors favor the diagnosis of primary malignant lymphoma of the CNS rather than that of “reticulum cell sarcoma” or “microgliomatosis” used in the past.
Journal ArticleDOI
Autopsy findings in the acquired immune deficiency syndrome.
Kevin Welch,Walter E. Finkbeiner,Charles E. Alpers,Walter Blumenfeld,Richard L. Davis,Edward A. Smuckler,Jay H. Beckstead +6 more
TL;DR: The most consistent and striking autopsy finding was a severe depletion of lymphoid tissues, which was attributable to opportunistic infections affecting most commonly the respiratory tract and meninges.
Journal ArticleDOI
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.
Penny K. Sneed,Paul R. Stauffer,Michael W. McDermott,Chris J. Diederich,Kathleen R. Lamborn,Michael D. Prados,Susan M. Chang,Keith A. Weaver,Laura Spry,Mary Malec,Sharon Lamb,Brigid Voss,Richard L. Davis,William M. Wara,David A. Larson,Theodore L. Phillips,Philip H. Gutin +16 more
TL;DR: Adjuvant interstitial brain HT, given before and after brachytherapy boost, after conventional radiotherapy significantly improves survival of patients with focal glioblastoma, with acceptable toxicity.